European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Galactooligosaccharide (GOS) Changes Fatty Acid Composition, Reduces Branched Short-Chain Fatty Acids, Ammonium in Colonic Fermentation Model January 18, 2023 Hong Kong Researchers Examine Synbiotic Preparation for Post-COVID-19 Syndrome in Randomized, Double Blind, Placebo-Controlled Study January 17, 2024 Fermentation of Pleurotus ostreatus and Ganoderma lucidum mushrooms and their extracts by the gut microbiota of healthy and osteopenic women: potential prebiotic effect and impact of mushroom fermentation products on human osteoblasts February 1, 2021
Galactooligosaccharide (GOS) Changes Fatty Acid Composition, Reduces Branched Short-Chain Fatty Acids, Ammonium in Colonic Fermentation Model January 18, 2023
Hong Kong Researchers Examine Synbiotic Preparation for Post-COVID-19 Syndrome in Randomized, Double Blind, Placebo-Controlled Study January 17, 2024
Fermentation of Pleurotus ostreatus and Ganoderma lucidum mushrooms and their extracts by the gut microbiota of healthy and osteopenic women: potential prebiotic effect and impact of mushroom fermentation products on human osteoblasts February 1, 2021